News and blogs
9 results found.
Clinical trials can give people with blood cancer hope
Rachel contacted the Clinical Trials Support Service to find out whether she could potentially take part in a clinical trial and contribute to blood cancer research.
Blood Cancer UK renews partnership with RareCan to accelerate research into rare cancers
Renewing the partnership will continue to grow RareCan’s patient community, offering more individuals living with a rare blood cancer diagnosis the opportunity to volunteer to take part in clinical research.
Read Ed's story of being diagnosed with CLL
Ed shares his story of how our Clinical Trials Support Service helped support him through his diagnosis of CLL
"I am incredibly happy to be alive and I am glad I took part [in the clinical trial]"
When Shibu was diagnosed with blood cancer in 2006, cord blood transplants were a 'new concept'. After struggling to find a bone marrow donor, Shibu was offered a place on a trial where he'd receive a cord blood transplant. Here's how it went.
Supporting people with blood cancer to make decisions around clinical trials
Find out how Millie, an Advanced Nurse Practitioner, helps people with blood cancer take decisions on blood cancer clinical trials.
I felt like I'd hit the jackpot: My experiences on a clinical trial
Learn more about Nicky's experience of taking part in a blood cancer clinical trial to treat chronic lymphocytic leukaemia (CLL) .
Deciding to take part in a chronic lymphocytic leukaemia (CLL) clinical trial - David's story
Read how the progression of David's CLL was reversed by taking ibrutinib as part of a blood cancer clinical trial.
Because my journey can help someone with theirs
It's been four and a half years since Jane achieved remission. Here, she reflects on the painful symptoms and "horrible" side effects of her blood cancer treatment, and explains that without taking part in a clinical trial, she wouldn't be here today.
Joining a clinical trial for lymphoma - Johanna's story
Johanna was diagnosed with chronic lymphocytic leukemia (CLL), find out why she joined a Blood Cancer UK clinical trial to control her leukaemia.
